⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SPRY News
ARS Pharmaceuticals, Inc. Common Stock
Class Action Lawsuit Filed: ARS Pharmaceuticals, Inc. (SPRY) - Join by October 5, 2026 - Contact Levi & Korsinsky
accessnewswire.com
SPRY
ARS Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SPRY
prnewswire.com
SPRY
SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law
prnewswire.com
SPRY
October 5, 2026 Deadline Approaching: Join Class Action Against ARS Pharmaceuticals, Inc. (SPRY) – Contact Levi & Korsinsky
accessnewswire.com
SPRY
Pomerantz LLP Notifies Shareholders of Class Action Against ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY
Securities Fraud Class Action Filed Against ARS Pharmaceuticals, Inc. (SPRY) – Levi & Korsinsky Reminds Investors of October 5, 2026
accessnewswire.com
SPRY
Pomerantz LLP Notifies Shareholders of Class Action Against ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY
SPRY INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds ARS Pharmaceuticals Investors of Securities Class Action Lawsuit Deadline on October 5, 2026 Ready to Announce with Confidence?
newsfilecorp.com
SPRY
Recover Investment Losses: Class Action Initiated Against ARS Pharmaceuticals, Inc. (SPRY)
accessnewswire.com
SPRY
Pomerantz LLP Notifies Investors of Class Action Lawsuit Against ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY